B. Kaplan

555 total citations
28 papers, 424 citations indexed

About

B. Kaplan is a scholar working on Transplantation, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Kaplan has authored 28 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Transplantation, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in B. Kaplan's work include Renal Transplantation Outcomes and Treatments (11 papers), Renal Diseases and Glomerulopathies (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). B. Kaplan is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Renal Diseases and Glomerulopathies (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). B. Kaplan collaborates with scholars based in United States, Canada and South Africa. B. Kaplan's co-authors include J. Katz, A. Lurie, H.-U. Meier-Kriesche, Peter D. Thomson, F. W. Wiglesworth, G M Macnab, Melvin I. Marks, K. N. Drummond, Paul Goodyer and J. Metz and has published in prestigious journals such as The Lancet, The Journal of Pediatrics and Transplantation.

In The Last Decade

B. Kaplan

28 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kaplan United States 11 157 149 107 102 68 28 424
C Loirat France 11 130 0.8× 176 1.2× 59 0.6× 20 0.2× 32 0.5× 29 369
Robert J. Postlethwaite United Kingdom 8 86 0.5× 160 1.1× 62 0.6× 48 0.5× 23 0.3× 15 306
Nadia Arzouk France 12 261 1.7× 151 1.0× 114 1.1× 77 0.8× 10 0.1× 27 461
CS Rosenfeld United States 10 212 1.4× 31 0.2× 195 1.8× 73 0.7× 16 0.2× 19 475
Martin Griebel Germany 10 49 0.3× 165 1.1× 18 0.2× 103 1.0× 88 1.3× 12 476
Mona Doshi United States 10 51 0.3× 147 1.0× 76 0.7× 37 0.4× 49 0.7× 12 351
Godfrey Clark United Kingdom 9 38 0.2× 58 0.4× 34 0.3× 104 1.0× 29 0.4× 20 267
Renu Regunathan-Shenk United States 7 135 0.9× 162 1.1× 43 0.4× 36 0.4× 44 0.6× 14 313
Glassock Rj United States 9 66 0.4× 181 1.2× 29 0.3× 13 0.1× 61 0.9× 22 337
Ogg Cs United Kingdom 12 50 0.3× 235 1.6× 26 0.2× 17 0.2× 110 1.6× 17 374

Countries citing papers authored by B. Kaplan

Since Specialization
Citations

This map shows the geographic impact of B. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kaplan more than expected).

Fields of papers citing papers by B. Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kaplan. The network helps show where B. Kaplan may publish in the future.

Co-authorship network of co-authors of B. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kaplan. A scholar is included among the top collaborators of B. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kaplan. B. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shihab, Fuad S., David R. Shaffer, Yasir Qazi, et al.. (2014). Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.. Transplantation. 98. 537–537. 3 indexed citations
2.
Shaffer, David R., Yasir Qazi, Fuad S. Shihab, et al.. (2014). Management of the Wound Complications in De Novo Renal Transplant Recipients: US92 12-Month Randomized Study.. Transplantation. 98. 542–543. 4 indexed citations
4.
Meier-Kriesche, H.-U. & B. Kaplan. (2001). Death after graft loss: a novel endpoint for renal tranplantation. Transplantation Proceedings. 33(7-8). 3405–3406. 40 indexed citations
5.
Matalon, Albert, Glen S. Markowitz, R. E. Joseph, et al.. (2001). Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.. PubMed. 56(4). 271–8. 46 indexed citations
6.
Meier-Kriesche, H.-U., et al.. (2000). DACLIZUMAB DECREASES ACUTE REJECTION IN AFRICAN AMERICAN AND HISPANIC RENAL TRANSPLANT RECIPIENTS.. Transplantation. 69(Supplement). S156–S156. 2 indexed citations
7.
Meier-Kriesche, H.-U., et al.. (2000). WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN STABLE RENAL TRANSPLANT RECIPIENTS.. Transplantation. 69(Supplement). S132–S132. 2 indexed citations
8.
Meier-Kriesche, H.-U., S. Mulgaonkar, Gary S. Friedman, et al.. (1999). EFFICACY OF DACLIZUMAB IN A HIGH RISK INNER CITY AFRICAN AMERICAN AND HISPANIC RENAL TRANSPLANT POPULATION. Transplantation. 67(7). S158–S158. 1 indexed citations
9.
Sollinger, H W, B. Kaplan, Mark D. Pescovitz, et al.. (1999). A MULTICENTER, RANDOMIZED TRIAL OF SIMULECT® WITH EARLY NEORAL® VS. ATGAM® WITH DELAYED NEORAL® IN RENAL TRANSPLANTATION. A 6-MONTH INTERIM ANALYSIS.. Transplantation. 67(7). S151–S151. 7 indexed citations
10.
Milner, Lawrence S., et al.. (1987). Colchicine Reduces Proteinuria in Passive Heymann Nephritis. ˜The œNephron journals/Nephron journals. 46(1). 11–17. 4 indexed citations
11.
Kaplan, B., et al.. (1986). Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis.. PubMed. 107(5). 425–30. 9 indexed citations
12.
Goodyer, Paul, J P de Chadarévian, & B. Kaplan. (1978). Acute poststreptococcal glomerulonephritis mimicking Henoch-Schönlein purpura. The Journal of Pediatrics. 93(3). 412–415. 24 indexed citations
13.
Kaplan, B., et al.. (1975). Extensive intraglomerular fibrin deposition after renal transplantation: recovery without anticoagulation.. PubMed. 112(7). 852–3. 1 indexed citations
14.
Chesney, Russell W. & B. Kaplan. (1974). Hemolytic-uremic syndrome with shigellosis. The Journal of Pediatrics. 84(2). 312–313. 7 indexed citations
15.
Kaplan, B., Peter D. Thomson, & G M Macnab. (1973). SERUM-COMPLEMENT LEVELS IN HÆMOLYTIC-URÆMIC SYNDROME. The Lancet. 302(7844). 1505–1506. 32 indexed citations
16.
Kaplan, B., F. W. Wiglesworth, Melvin I. Marks, & K. N. Drummond. (1972). The glomerulopathy of congenital syphilis—an immune deposit disease. The Journal of Pediatrics. 81(6). 1154–1156. 43 indexed citations
17.
Katz, J., et al.. (1971). Coagulation findings in the hemolytic-uremic syndrome of infancy: Similarity to hyperacute renal allograft rejection. The Journal of Pediatrics. 78(3). 426–434. 38 indexed citations
18.
Kaplan, B., et al.. (1971). An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome. The Journal of Pediatrics. 78(3). 420–425. 80 indexed citations
19.
Kaplan, B. & H J Koornhof. (1969). HÆMOLYTIC-URÆMIC SYNDROME: FAILURE TO DEMONSTRATE CIRCULATING ENDOTOXIN. The Lancet. 294(7635). 1424–1425. 16 indexed citations
20.
Katz, J., A. Lurie, & B. Kaplan. (1969). HÆMOLYTIC-URÆMIC SYNDROME AND HEPARIN THERAPY. The Lancet. 294(7622). 700–700. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026